Filing Details
- Accession Number:
- 0001628280-20-004374
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-30 16:56:14
- Reporting Period:
- 2020-03-26
- Accepted Time:
- 2020-03-30 16:56:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 771856 | Champions Oncology Inc. | CSBR | Biological Products, (No Disgnostic Substances) (2836) | 521401755 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1327897 | Newman Daniel Mendelson | C/O Champions Oncology, Inc. One University Plaza, Suite 307 Hackensack NJ 07601 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-03-26 | 20 | $6.00 | 57,546 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-03-26 | 100 | $5.99 | 57,646 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-03-26 | 100 | $5.97 | 57,746 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-03-26 | 700 | $5.90 | 58,446 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-03-26 | 300 | $5.89 | 58,746 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
